Abiopharma

🔍 Wilson Daniel G. (Executive)

Company: iRhythm Technologies, Inc. (IRTC)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 737 shares of Common Stock at $167.28 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 39,470.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: H | nature_of_ownership: Held through a Family Trust | shares_owned_after: 100.00 | Footnotes: F2

Footnotes:

• F1: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.
• F2: These shares represent an indirect ownership through The Wilson Living Trust dated July 9, 2015, of which Mr. Wilson is the Trustee.